311 related articles for article (PubMed ID: 24732188)
1. Therapeutic options for functional dyspepsia.
Vanheel H; Tack J
Dig Dis; 2014; 32(3):230-4. PubMed ID: 24732188
[TBL] [Abstract][Full Text] [Related]
2. [Functional Dyspepsia].
Oh JH; Kwon JG
Korean J Gastroenterol; 2019 Feb; 73(2):77-83. PubMed ID: 30845383
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.
Xiao YL; Peng S; Tao J; Wang AJ; Lin JK; Hu PJ; Chen MH
Am J Gastroenterol; 2010 Dec; 105(12):2626-31. PubMed ID: 20823838
[TBL] [Abstract][Full Text] [Related]
4. Drugs under development for the treatment of functional dyspepsia and related disorders.
Tack J; Masuy I; Van Den Houte K; Wauters L; Schol J; Vanuytsel T; Vandenberghe A; Carbone F
Expert Opin Investig Drugs; 2019 Oct; 28(10):871-889. PubMed ID: 31566013
[No Abstract] [Full Text] [Related]
5. Rome III functional dyspepsia subdivision in PDS and EPS: recognizing postprandial symptoms reduces overlap.
Carbone F; Holvoet L; Tack J
Neurogastroenterol Motil; 2015 Aug; 27(8):1069-74. PubMed ID: 26220647
[TBL] [Abstract][Full Text] [Related]
6. A review of drug therapy for functional dyspepsia.
Chen SL
J Dig Dis; 2013 Dec; 14(12):623-5. PubMed ID: 23957752
[TBL] [Abstract][Full Text] [Related]
7. Current and emerging therapeutic options for the management of functional dyspepsia.
Vandenberghe A; Schol J; Van den Houte K; Masuy I; Carbone F; Tack J
Expert Opin Pharmacother; 2020 Feb; 21(3):365-376. PubMed ID: 31899982
[No Abstract] [Full Text] [Related]
8. [Guidelines for the treatment of functional dyspepsia].
Jee SR; Jung HK; Min BH; Choi KD; Rhee PL; Kang YW; Lee SI;
Korean J Gastroenterol; 2011 Feb; 57(2):67-81. PubMed ID: 21350319
[TBL] [Abstract][Full Text] [Related]
9. Functional dyspepsia: new insights into pathogenesis and therapy.
Talley NJ
Korean J Intern Med; 2016 May; 31(3):444-56. PubMed ID: 27048251
[TBL] [Abstract][Full Text] [Related]
10. Current management strategies and emerging treatments for functional dyspepsia.
Camilleri M; Stanghellini V
Nat Rev Gastroenterol Hepatol; 2013 Mar; 10(3):187-94. PubMed ID: 23381190
[TBL] [Abstract][Full Text] [Related]
11. Acotiamide, a novel gastroprokinetic for the treatment of patients with functional dyspepsia: postprandial distress syndrome.
Altan E; Masaoka T; Farré R; Tack J
Expert Rev Gastroenterol Hepatol; 2012 Sep; 6(5):533-44. PubMed ID: 23061703
[TBL] [Abstract][Full Text] [Related]
12. Rome III criteria cannot distinguish patients with chronic gastritis from those functional dyspepsia patients.
Wei Z; Ying L; Wen G; Mengnan Z; Yali Z
Helicobacter; 2014 Apr; 19(2):124-8. PubMed ID: 24617669
[TBL] [Abstract][Full Text] [Related]
13. Review article: current treatment options and management of functional dyspepsia.
Lacy BE; Talley NJ; Locke GR; Bouras EP; DiBaise JK; El-Serag HB; Abraham BP; Howden CW; Moayyedi P; Prather C
Aliment Pharmacol Ther; 2012 Jul; 36(1):3-15. PubMed ID: 22591037
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification.
Suzuki H; Nishizawa T; Hibi T
J Gastroenterol; 2006 Jun; 41(6):513-23. PubMed ID: 16868798
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs for functional dyspepsia.
Zala AV; Walker MM; Talley NJ
Expert Opin Emerg Drugs; 2015 Jun; 20(2):221-33. PubMed ID: 25645940
[TBL] [Abstract][Full Text] [Related]
16. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia.
Wauters L; Dickman R; Drug V; Mulak A; Serra J; Enck P; Tack J; ; Accarino A; Barbara G; Bor S; Coffin B; Corsetti M; De Schepper H; Dumitrascu D; Farmer A; Gourcerol G; Hauser G; Hausken T; Karamanolis G; Keszthelyi D; Malagelada C; Milosavljevic T; Muris J; O'Morain C; Papathanasopoulos A; Pohl D; Rumyantseva D; Sarnelli G; Savarino E; Schol J; Sheptulin A; Smet A; Stengel A; Storonova O; Storr M; Törnblom H; Vanuytsel T; Velosa M; Waluga M; Zarate N; Zerbib F
United European Gastroenterol J; 2021 Apr; 9(3):307-331. PubMed ID: 33939891
[TBL] [Abstract][Full Text] [Related]
17. Symptom overlap between postprandial distress and epigastric pain syndromes of the Rome III dyspepsia classification.
Vakil N; Halling K; Ohlsson L; Wernersson B
Am J Gastroenterol; 2013 May; 108(5):767-74. PubMed ID: 23567354
[TBL] [Abstract][Full Text] [Related]
18. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.
Hojo M; Nagahara A; Asaoka D; Takeda T; Izumi K; Matsumoto K; Ueyama H; Shimada Y; Matsumoto K; Nojiri S; Watanabe S
Digestion; 2017; 96(1):5-12. PubMed ID: 28605740
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic strategies for the treatment of dyspepsia.
Kandulski A; Venerito M; Malfertheiner P
Expert Opin Pharmacother; 2010 Oct; 11(15):2517-25. PubMed ID: 20726822
[TBL] [Abstract][Full Text] [Related]
20. Fasting and postprandial gastric sensorimotor activity in functional dyspepsia: postprandial distress vs. epigastric pain syndrome.
Di Stefano M; Miceli E; Tana P; Mengoli C; Bergonzi M; Pagani E; Corazza GR
Am J Gastroenterol; 2014 Oct; 109(10):1631-9. PubMed ID: 25199472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
